Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-22

Clinical Trial Update: Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the safety and preliminary efficacy of extracorporeal shockwave therapy in patients with resistant hypertension, sponsored by Medisp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extracorporeal shockwave therapy (Shockwave therapy)

Snippet

Sponsor: Medispec | Conditions: Hypertension, Resistant to Conventional Therapy | Phase 1 | Status: UNKNOWN